Literature DB >> 3166888

UKCCCR guidelines for the welfare of animals in experimental neoplasia.

.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3166888      PMCID： PMC2246499          DOI： 10.1038/bjc.1988.174

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop.

Authors:  R F Kallman; J M Brown; J Denekamp; R P Hill; J Kummermehr
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

2.  The adenoma-carcinoma sequence in AMMN-induced colonic tumors of the rat.

Authors:  P J Hermanek; J Giedl
Journal:  Pathol Res Pract       Date:  1984-07       Impact factor: 3.250

3.  Role of murine tumor models in cancer treatment research.

Authors:  D S Martin; M E Balis; B Fisher; E Frei; E J Freireich; G H Heppner; J F Holland; J A Houghton; P J Houghton; R K Johnson
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701
  3 in total
  17 in total

1.  Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.

Authors:  G Milan; A Zambon; M Cavinato; P Zanovello; A Rosato; D Collavo
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

2.  Of mice and men: the evolution of animal welfare guidelines for cancer research.

Authors:  N Dey; P De; B R Smith; B Leyland-Jones
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

3.  Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.

Authors:  A Guaitani; M Corada; C Lucas; A Lemoine; S Garattini; I Bartosek
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.

Authors:  Y Takamiya; Y Abe; Y Tanaka; A Tsugu; M Kazuno; Y Oshika; K Maruo; Y Ohnishi; O Sato; H Yamazaki; H Kijima; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation.

Authors:  M Tachibana; A Miyakawa; J Nakashima; M Murai; K Nakamura; A Kubo; J I Hata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.

Authors:  M De Cesare; G Pratesi; A Giusti; D Polizzi; F Zunino
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Authors:  G Pratesi; P Perego; D Polizzi; S C Righetti; R Supino; C Caserini; C Manzotti; F C Giuliani; G Pezzoni; S Tognella; S Spinelli; N Farrell; F Zunino
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

8.  Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo.

Authors:  S Hazama; T Noma; F Wang; N Iizuka; Y Ogura; K Yoshimura; E Inoguchi; M Hakozaki; K Hirose; T Suzuki; M Oka
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

9.  The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.

Authors:  P K Quinn; M C Bibby; J A Cox; S M Crawford
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

10.  Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice.

Authors:  P Topley; D C Jenkins; E A Jessup; J N Stables
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.